Point72 Asset Management, L.P.
Position in ATRA — Atara Biotherapeutics, Inc.
CIK 1603466
STAMFORD, CT
Position in ATRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,895,002
+$6,976,134 QoQ
Shares Held
687,718
+254.0% QoQ
Ownership
6.85%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3
of 36 holders
Holding Since
Jun 2020
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ATRA Over Time
Shares Held
Position Value (USD)
Derivatives in ATRA
reported options exposure · as of Jun 30, 2022CallValue
$395,732
CallShares
2,032
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. ATRA ranks #62 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in ATRA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,895,002 | 687,718 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $7,895,002 | 687,718 | Shares | Sole | 2026-08-14 | |
| 2026-05-07 | $5,229,952 | 526,682 | Shares | Sole | 2026-05-08 | |
| 2026-03-31 | $918,868 | 194,264 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $330,974 | 18,296 | Shares | Defined | 2026-02-17 | |
| 2023-09-30 | $821,400 | 555,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $921,291 | 572,231 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $79,048 | 27,258 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $113,400 | 30,000 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $395,732 | 50,800 | Call | Defined | 2022-08-15 | |
| 2022-06-30 | $30,203,388 | 3,877,200 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $929,000 | 100,000 | Call | Defined | 2022-05-16 | |
| 2022-03-31 | $38,123,150 | 4,103,676 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $72,711,912 | 4,613,700 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $41,497,570 | 2,318,300 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,505,445 | 739,900 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,712,756 | 537,100 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $22,099,454 | 1,125,800 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $1,934,225 | 132,754 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||